Kingmed Diagnostics
Healthcare Services · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Haizhu Science and Technology Building 2...Phone Number
+86 2022283222Website
www.kingmed.com.cnRevenue
$17 MillionIndustry
About Kingmed Diagnostics
Kingmed Diagnostics Org Chart
Is Kingmed Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Kingmed Diagnostics had a recent Job posting/layoffs
Kingmed Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Kingmed Diagnostics
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Kingmed Diagnostics has new funding data
Product Launch: Get notified when Kingmed Diagnostics launches new products
Check if Kingmed Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Check out if Kingmed Diagnostics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Kingmed Diagnostics recently announced quarterly report
Recommended Actions
Find VP level buyers at Kingmed Diagnostics
Find more new buyers
Company Profile Activity
Activity Insights
Kingmed Diagnostics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Kingmed Diagnostics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Kingmed Diagnostics.
Kingmed Diagnostics Tech Stack
A closer look at the technologies used by Kingmed Diagnostics
Kingmed Diagnostics News & Media
Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval
Companies Target Review Aimed at Molecular Oncology and Hereditary Diseases SAN DIEGO--(BUSINESS WIRE)--Jan. 4, 2018-- Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a starting poIllumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a starting point to deliver precision medicine to patients throughout China. Under the agreement, Illum
Top Healthcare Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Kingmed Diagnostics
金域医学 is a third-party medical testing and pathology diagnosis service provider catering to various medical institutions. The company offers comprehensive clinical diagnostic information services, health management solutions, and integrated laboratory management solutions. They focus on utilizing advanced technologies and data analytics to support c... Read More